Brogan, A J <br/><br/>
Is increased screening and early antiretroviral treatment for HIV-1 worth the investment? An analysis of the public health and economic impact of improvement in the UK.  [electronic resource] 

 -  HIV medicine  11 2019 
 - 668-680 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-1293 
<br/><br/><label>Standard No.: </label>10.1111/hiv.12788  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Cost-Benefit Analysis<br/>Female<br/>HIV Infections--diagnosis<br/>HIV-1<br/>Health Care Costs<br/>Humans<br/>Male<br/>Markov Chains<br/>Mass Screening--economics<br/>Middle Aged<br/>Public Health<br/>Quality-Adjusted Life Years<br/>United Kingdom